GlassScriptPhysician profile
Johnny S Chung
NPI 1932188620
$18,918.22
in general payments reported to CMS, 2019-2025
23 companies · $1,526 in 2025
The $1,526 reported for 2025 was more than what 79% of Plastic and Reconstructive Surgery providers received nationally (typical 2025 total: $445).
See the full distribution for Plastic and Reconstructive Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2020: $654 · 2021: $4,463 · 2022: $667 · 2023: $126 · 2024: $234 · 2025: $1,526.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $963 · Travel and Lodging: $924.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $962.63 |
| Travel and Lodging | $923.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $15,863.69 | 2019-2022 | |
| Novus Surgical Consultants | $695.90 | 2025 | |
| Merz North America, INC. | $474.16 | 2019-2022 | |
| Arthrex, INC. | $447.66 | 2025 | |
| Mentor Worldwide LLC | $420.74 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander |
| Revance Therapeutics, INC. | $251.93 | 2024-2025 | Daxxify |
| Abbvie INC. | $146.28 | 2021-2025 | Botox |
| Incyte Corporation | $110.80 | 2022-2025 | Opzelura |
| Sun Pharmaceutical Industries INC. | $93.27 | 2022-2025 | Ilumya |
| Galderma Laboratories, L.P. | $67.64 | 2020-2024 | |
| Janssen Biotech, INC. | $57.82 | 2020-2025 | Tremfya |
| Misonix INC | $45.81 | 2021 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $39.59 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $39.09 | 2021-2022 | |
| Biofrontera INC. | $26.46 | 2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Almirall LLC | $24.00 | 2022 | |
| Medtronic, INC. | $22.22 | 2024 | Onyx 18 |
| Esperion Therapeutics, INC. | $17.78 | 2022 | |
| Leo Pharma INC. | $17.23 | 2021 | |
| Teleflex LLC | $16.96 | 2024 | Arrow |
| Kowa Pharmaceuticals America, INC. | $14.72 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $13.59 | 2025 | |
| Musculoskeletal Transplant Foundation INC. | $10.88 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Johnny Chung listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.